Dopamine agonist for Lactotroph adenoma [Neurosurgery Wiki]

This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong.

====== Dopamine agonist for Lactotroph adenoma ======

[[Lactotroph adenoma]] is the only type of [[pituitary tumor]] for which [[medical therapy]] ([[Dopamine agonist]]s) may be the primary treatment in certain cases.
----
[[Dopamine agonist]]s such as [[bromocriptine]] and [[cabergoline]] have been found to be an effective treatment for [[hyperprolactinemia]], not only inducing adenoma shrinkage but also lowering serum [[prolactin]] levels. Among known dopamine agonists, cabergoline is the drug of choice due to its enhanced tolerability compared with bromocriptine
((Krysiak R, Okopien B. Different Effects of Cabergoline and Bromocriptine on
Metabolic and Cardiovascular Risk Factors in Patients with Elevated Prolactin
Levels. Basic Clin Pharmacol Toxicol. 2014 Aug 13. doi: 10.1111/bcpt.12307. [Epub
ahead of print] PubMed PMID: 25123447.)). 

see [[Dopamine agonist resistant lactotroph adenoma]].